Walter T. Walker, III v. Action Industries, Inc. Amos Comay Sholom D. Comay Ernest S. Berez

802 F.2d 703, 1986 U.S. App. LEXIS 31466, 41 Empl. Prac. Dec. (CCH) 36,943, 55 U.S.L.W. 2248
CourtCourt of Appeals for the Fourth Circuit
DecidedOctober 1, 1986
Docket85-1407
StatusPublished
Cited by46 cases

This text of 802 F.2d 703 (Walter T. Walker, III v. Action Industries, Inc. Amos Comay Sholom D. Comay Ernest S. Berez) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Walter T. Walker, III v. Action Industries, Inc. Amos Comay Sholom D. Comay Ernest S. Berez, 802 F.2d 703, 1986 U.S. App. LEXIS 31466, 41 Empl. Prac. Dec. (CCH) 36,943, 55 U.S.L.W. 2248 (4th Cir. 1986).

Opinion

ERVIN, Circuit Judge:

Walter T. Walker, III, appeals the jury verdict against him on his claim for violations of § 10(b) 1 of the Securities Exchange Act of 1934 and SEC rule 10b-5 2 based on , alleged material omissions in a tender offer statement and press release issued by Action Industries, Inc. (Action). Walker also appeals the district court’s directed verdict on his state law claim against certain directors of Action for breach of fiduciary duty, the court’s denial of his motion for class certification, various evidentiary rulings and allegedly prejudicial comments by the trial judge. We conclude that the jury was instructed properly that the corporation did not have a duty to disclose its financial projections. Thus, the jury’s verdict on the rule 10b-5 claim is unimpeachable. We also conclude that Walker’s other bases for challenging the judgment below do not constitute reversible error. Accordingly, we affirm.

I.

On July 16, 1982, Action 3 made a tender offer to purchase 15% of its common stock at $4.00 per share until August 6. In connection with the tender offer, Action issued a tender offer statement pursuant to rule 13e-4, 4 which contained financial information on the corporation. Action’s fiscal year runs from July through June. The tender offer statement disclosed audited financial statements for fiscal years 1979, 1980 and 1981. These figures revealed a net loss of $2,306,900 in fiscal 1979, net earnings of $372,900 in fiscal 1980, and net earnings of $731,200 in fiscal 1981. Because the 1982 fiscal year had just ended, audited financial statements for that year were not available. Action did disclose, however, unaudited, interim financial statements for fiscal 1982 through March 27, 1982, the end of Action’s third fiscal quarter. These figures indicated a net loss of $4,014,900 as compared with net earnings of $1,037,600 for the same period in the previous year. In § 14B of the tender offer statement, Action also made disclosures entitled “Events Subsequent to March 27, 1982,” which stated in part:

The Company’s fiscal year ended on June 26, 1982. Although financial statements *705 have not yet been prepared or audited, the Company expects results from continuing operations to reflect a sales increase compared with the prior year. However, earnings from continuing operations are estimated to be somewhat lower than last year as a result of lower gross margins on sales and higher operating expenses.

In addition to financial statements, Action regularly prepared a number of other financial reports internally. On a weekly basis, Action prepared “work projections,” which recorded actual orders and identified them as “firm” or “anticipated,” depending on their likelihood of cancellation. Approximately monthly, Action prepared “gross sales forecasts.” These reports projected monthly and quarterly sales based on the orders reflected in the weekly work projections. Action also tracked actual financial results in weekly “flash sales reports,” which showed sales for the current week, month-to-date sales and quarter-to-date sales.

As early as May 1982, Action’s internal financial reports indicated substantial increases in actual orders and projected sales for the first quarter of fiscal 1983 over the same period for fiscal 1982. As the July 16 tender offer grew nearer, and the first quarter of fiscal 1983 began, subsequent internal reports indicated even more substantial increases in actual orders and projected sales, as well as increases in actual sales over the prior year. Action, however, did not disclose the projected increases in sales or the increases in actual orders and sales in the tender offer statement, which was issued approximately twenty days into its first quarter of fiscal 1983.

At the time of the tender offer, Walker owned 2000 shares of Action which he had purchased in April 1982, at $3.25 per share. Walker learned of the July 16 tender offer from his broker, and based on that information, anticipated improved prospects for the company. Then, on July 21, without actually having received or read the tender offer statement, Walker purchased an additional 1500 shares of Action at $4.00 per share. Subsequently, Walker received and read the tender offer statement. The tender offer ended on August 6 without Walker having tendered or sold any of his shares.

On August 18, 1982, Action issued a press release regarding its year-end financial results for fiscal 1982. The press release and Action’s audited financial statements, on which the press release was based, essentially confirmed the statements made in § 14B of the tender offer statement regarding the company’s financial performance in fiscal 1982; sales were up but earnings were down. Between the time of the tender offer and the press release, Action’s internal financial reports continued to indicate substantial increases in projected sales, and actual orders and sales, for the company’s first quarter of fiscal 1983 and thereafter. As with the tender offer statement, however, Action refrained from disclosing such information in the press release. Walker read the press release and concluded that the company’s prospects were not favorable. On September 21, he sold all of his Action shares on the open market at approximately $5.25 per share.

Action’s stock traded as high as 7Vs per share on October 21. Then on October 28, Action issued a press release revealing its financial results for the first quarter of fiscal 1983 ending September 25, 1982. The release and accompanying unaudited, interim financial statements showed a 75% increase in sales, and net earnings of $1,467,600 compared with a net loss of $412,500, for the same period in the previous year. The following day, on October 29, Action stock traded as high as 9%. By November 12, the stock reached 15% per share. /

Subsequently, Wallcer brought suit against Action and three of its directors. Walker pursued a plaim under rule 10b-5 alleging that defendants had a duty to disclose financial projections and actual orders and sales for fiscal 1983 in the tender offer statement and the August 18 press release. Defendants’ failure to make such disclo *706 sures, alleged Walker, constituted omissions of material facts in violation of rule 10b-5. As damages, Walker sought the difference between the price he received for his shares on September 21 and the price he would have received if he had not sold them until November 12. Based on essentially the same allegations, Walker pursued a claim against the directors for breach of fiduciary duty under Pennsylvania’s common law. On his state law claim, Walker sought compensatory, as well as punitive damages.

Before trial, the district court denied Walker’s motion to have the suit certified as a class action and denied Action’s motion for dismissal or summary judgment. At trial, after the close of Walker’s case, the court granted Action’s motion for a directed verdict on Walker’s breach of fiduciary duty claim. Although the court removed the tender offer statement from the case, 5 Walker’s 10b-5 claim went to the jury for a determination of whether there were material omissions in the press release.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In re Novatel Wireless Securities Litigation
830 F. Supp. 2d 996 (S.D. California, 2011)
In Re Trex Co., Inc. Securities Litigation
454 F. Supp. 2d 560 (W.D. Virginia, 2006)
Glaser v. Enzo Biochem, Inc.
303 F. Supp. 2d 724 (E.D. Virginia, 2003)
Planned Parenthood of the Columbia/willamette, Inc. Portland Feminist Women's Health Center Robert Crist, M.D. Warren M. Hern, M.D. Elizabeth Newhall, M.D. James Newhall, M.D., and Karen Sweigert, M.D. v. American Coalition of Life Activists Advocates for Life Ministries Michael Bray Andrew Burnett David A. Crane Timothy Paul Dreste Michael B. Dodds Joseph L. Foreman Charles Roy McMillan Stephen P. Mears Bruce Evan Murch Catherine Ramey Dawn Marie Stover Charles Wysong, and Monica Migliorino Miller Donald Treshman, Planned Parenthood of the Columbia/willamette, Inc. Portland Feminist Women's Health Center Robert Crist, M.D. Warren M. Hern, M.D. Elizabeth Newhall, M.D. James Newhall, M.D., and Karen Sweigert, M.D. v. American Coalition of Life Activists Advocates for Life Ministries Michael Bray Andrew Burnett David A. Crane Timothy Paul Dreste Joseph L. Foreman Stephen P. Mears Monica Migliorino Miller Catherine Ramey Dawn Marie Stover Donald Treshman Charles Wysong, and Michael Dodds Charles Roy McMillan Bruce Evan Murch, Planned Parenthood of the Columbia/willamette, Inc. Portland Feminist Women's Health Center Robert Crist, M.D. Warren M. Hern, M.D. Elizabeth Newhall, M.D. James Newhall, M.D., and Karen Sweigert, M.D. v. American Coalition of Life Activists Advocates for Life Ministries Michael Bray Andrew Burnett David A. Crane Michael Dodds Charles Roy McMillan Stephen P. Mears Monica Migliorino Miller Bruce Evan Murch Catherine Ramey Dawn Marie Stover Donald Treshman, and Timothy Paul Dreste Joseph L. Foreman Charles Wysong, Planned Parenthood of the Columbia/willamette, Inc. Portland Feminist Women's Health Center Robert Crist, M.D. Warren M. Hern, M.D. Elizabeth Newhall, M.D. James Newhall, M.D., and Karen Sweigert, M.D. v. American Coalition of Life Activists Advocates for Life Ministries Michael Bray Andrew Burnett David A. Crane Catherine Ramey Dawn Marie Stover, and Timothy Paul Dreste Michael Dodds Joseph L. Foreman Charles Roy McMillan Stephen P. Mears Monica Migliorino Miller Bruce Evan Murch Donald Treshman Charles Wysong, Planned Parenthood of the Columbia/willamette, Inc. Portland Feminist Women's Health Center Robert Crist, M.D. Warren M. Hern, M.D. Elizabeth Newhall, M.D. James Newhall, M.D. v. American Coalition of Life Activists Advocates for Life Ministries Michael Bray Andrew Burnett David A. Crane Timothy Paul Dreste Michael B. Dodds Joseph L. Foreman Charles Roy McMillan Bruce Evan Murch Catherine Ramey Dawn Marie Stover Donald Treshman Charles Wysong, Paul Deparrie, Movant-Appellant. Planned Parenthood of the Columbia/willamette, Inc. Portland Feminist Women's Health Center Robert Crist, M.D. Warren M. Hern, M.D. Elizabeth Newhall, M.D. James Newhall, M.D. Karen Sweigert, M.D., Individually and on Behalf of All Persons Similarly Situated v. American Coalition of Life Activists Advocates for Life Ministries Michael Bray Andrew Burnett David Crane Timothy Paul Dreste Michael Dodds Joseph L. Foreman Charles Roy McMillan Monica Migliorino Miller Bruce Evan Murch Catherine Ramey Dawn Marie Stover Donald Treshman Charles Wysong
290 F.3d 1058 (Ninth Circuit, 2002)
Graff v. Prime Retail, Inc.
172 F. Supp. 2d 721 (D. Maryland, 2001)
Haney v. Delta Petroleum Co., Inc.
748 So. 2d 36 (Louisiana Court of Appeal, 1999)
Clark v. Allen
Fourth Circuit, 1998
Gasner v. Board of Supervisors
103 F.3d 351 (Fourth Circuit, 1997)
Connelly v. General Medical Corp.
880 F. Supp. 1100 (E.D. Virginia, 1995)
Herman v. Legent Corp.
50 F.3d 6 (Fourth Circuit, 1995)
PPM America, Inc. v. Marriott Corp.
875 F. Supp. 289 (D. Maryland, 1995)
In Re Medimmune, Inc. Securities Litigation
873 F. Supp. 953 (D. Maryland, 1995)
Hillson Partners Ltd. Partnership v. Adage, Inc.
42 F.3d 204 (Fourth Circuit, 1994)
Endo v. Albertine
863 F. Supp. 708 (N.D. Illinois, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
802 F.2d 703, 1986 U.S. App. LEXIS 31466, 41 Empl. Prac. Dec. (CCH) 36,943, 55 U.S.L.W. 2248, Counsel Stack Legal Research, https://law.counselstack.com/opinion/walter-t-walker-iii-v-action-industries-inc-amos-comay-sholom-d-comay-ca4-1986.